Bausch & Lomb (BLCO) EBIT Growth (3y) (2024 - 2026)
Powered by 
Analysis
Bausch & Lomb (BLCO) EBIT Growth (3y) (2024 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 3.16% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 28.02% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 11.63% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 19.80% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 31.84% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 24.88% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -65.59% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 35.44% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 13.06% |
| 10 | Bausch & Lomb | 6.28 Bn | 5.90 Bn | 867.00 Mn | 24.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 24.51% |
| Mar 31, 2026 | 164.48% |
| Dec 31, 2025 | 29.98% |
| Sep 30, 2025 | 27.35% |
| Jun 30, 2025 | -29.99% |
| Mar 31, 2025 | -52.36% |
| Dec 31, 2024 | -1.85% |
| Sep 30, 2024 | -22.95% |
| Jun 30, 2024 | -23.47% |
| Mar 31, 2024 | -58.67% |